SecSonar.com

MaxCyte, Inc. (MXCT)

MaxCyte, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

MaxCyte, Inc. (MXCT) is a Medical - Devices company based in US with a market capitalization of $135.5M. Revenue declined 14.5% year-over-year and free cash flow was negative at -$36.2M. This page tracks MXCT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 114 employees · IPO Jul 30, 2021

Valuation

Valuation & price

$1.04 · as of May 17, 2026 · -55.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.79

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.33$1.50$0.68Jul 25Dec 25Jul 26Jul 7, 25$2.17Jul 9, 25$2.25Jul 11, 25$2.22Jul 15, 25$2.11Jul 17, 25$2.15Jul 21, 25$2.10Jul 23, 25$2.33Jul 25, 25$2.25Jul 29, 25$2.12Jul 31, 25$2.06Aug 4, 25$2.08Aug 6, 25$2.04Aug 11, 25$1.32Aug 13, 25$1.38Aug 15, 25$1.36Aug 19, 25$1.40Aug 21, 25$1.42Aug 25, 25$1.39Aug 27, 25$1.40Aug 29, 25$1.39Sep 3, 25$1.38Sep 5, 25$1.41Sep 9, 25$1.42Sep 11, 25$1.48Sep 16, 25$1.48Sep 18, 25$1.62Sep 22, 25$1.55Sep 24, 25$1.66Sep 26, 25$1.53Sep 30, 25$1.58Oct 2, 25$1.61Oct 6, 25$1.65Oct 8, 25$1.70Oct 10, 25$1.54Oct 14, 25$1.65Oct 16, 25$1.77Oct 21, 25$1.71Oct 23, 25$1.62Oct 27, 25$1.54Oct 29, 25$1.51Oct 31, 25$1.54Nov 4, 25$1.61Nov 6, 25$1.47Nov 10, 25$1.47Nov 12, 25$1.58Nov 14, 25$1.58Nov 18, 25$1.71Nov 20, 25$1.63Nov 25, 25$1.70Nov 28, 25$1.76Dec 2, 25$1.57Dec 4, 25$1.58Dec 8, 25$1.55Dec 10, 25$1.54Dec 12, 25$1.52Dec 16, 25$1.47Dec 18, 25$1.52Dec 22, 25$1.63Dec 24, 25$1.60Dec 29, 25$1.58Jan 2, 26$1.55Jan 6, 26$1.50Jan 8, 26$1.47Jan 12, 26$1.36Jan 14, 26$1.28Jan 16, 26$1.26Jan 21, 26$1.23Jan 23, 26$1.16Jan 27, 26$1.07Jan 29, 26$0.98Feb 2, 26$0.87Feb 4, 26$0.87Feb 9, 26$0.79Feb 11, 26$0.73Feb 13, 26$0.72Feb 18, 26$0.68Feb 20, 26$0.74Feb 24, 26$0.79Feb 26, 26$0.79Mar 2, 26$0.79Mar 4, 26$0.77Mar 6, 26$0.78Mar 10, 26$0.79Mar 12, 26$0.83Mar 17, 26$0.80Mar 19, 26$0.75Mar 23, 26$0.76Mar 25, 26$0.69Mar 27, 26$0.68Mar 31, 26$0.70Apr 2, 26$0.75Apr 7, 26$0.71Apr 9, 26$0.76Apr 13, 26$0.82Apr 15, 26$0.85Apr 17, 26$0.85Apr 22, 26$0.89Apr 24, 26$0.86Apr 28, 26$0.88Apr 30, 26$0.88May 4, 26$0.86May 6, 26$0.85May 8, 26$0.84May 12, 26$0.82May 14, 26$1.09May 18, 26$1.06May 20, 26$1.07May 22, 26$1.04May 28, 26$1.17Jun 1, 26$1.22Jun 3, 26$1.20Jun 5, 26$1.14Jun 9, 26$1.19Jun 11, 26$1.10Jun 15, 26$1.16Jun 17, 26$1.13Jun 22, 26$1.18Jun 24, 26$1.19Jun 26, 26$1.24Jul 2, 26$1.22
$0.6852-week range$2.33
Loading valuation history…

Fundamentals

Key fundamentals

$135.5M

Market cap

-14.5%

Revenue growth (YoY)

81.2%

Gross margin

-$36.2M

Free cash flow (USD)

-$85.1M

Net debt

Net cash position

1.5%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$12.3MFY 2017$14.0MFY 2018$16.7MFY 2019$21.6MFY 2020$26.2MFY 2021$33.9MFY 2022$44.3MFY 2023$41.3MFY 2024$38.6MFY 2025$33.0M
$12.3M$33M

Free cash flow by year

2016 → 2025

FY 2016$-2.6MFY 2017$-10.3MFY 2018$-11.2MFY 2019$-10.1MFY 2020$-10.9MFY 2021$-14.5MFY 2022$-33.3MFY 2023$-25.4MFY 2024$-29.3MFY 2025$-36.2M
-$2.6M-$36.2M

Gross margin by year

2021 → 2025

FY 202189.2%FY 202288.5%FY 202388.5%FY 202481.6%FY 202581.2%
89.2%81.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 17, 2026Filing
  • 8-K eventRegained ComplianceJun 16, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing

Questions

Frequently asked questions

What is MaxCyte, Inc.'s market cap?

MaxCyte, Inc. (MXCT) has a market capitalization of $135.5M.

What is MXCT's P/E ratio?

A meaningful P/E ratio is not available for MXCT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is MXCT's price-to-book (P/B) ratio?

MXCT trades at 0.79 times book value per share.

Are insiders buying MXCT stock?

SEC Form 4 filings show no open-market insider buys at MaxCyte, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

NNOX

Nano-X Imaging Ltd.

$134.7M

QTI

QT Imaging Holdings, Inc.

$136.9M

HYPR

Hyperfine, Inc.

$133.5M

TLSI

TriSalus Life Sciences, Inc.

$128.5M

SNWV

SANUWAVE Health, Inc.

$143.2M

QTRX

Quanterix Corporation

$146.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.